Top Markets
#1 Akedo Akedo +58.73%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +47.62%
#4 Velvet Velvet +38.36%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cross Cross +27.05%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.76%
#8 QANplatform QANplatform +14.60%
#9 Perle Perle +14.17%
#10 Bitway Bitway +13.96%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
MedAvail Holdings, Inc. MedAvail Holdings, Inc.

MedAvail Holdings, Inc.

MDVL
Rank in Stocks #38562
MedAvail Holdings, Inc. is a pioneer in tech-driven retail pharmacy solutions,... MedAvail Holdings, Inc. is a pioneer in tech-driven retail pharmacy solutions, focusing on both the technology itself and related services. The company designs and markets a range of innovative offerings, including self-service pharmacy units, mobile applications, interactive kiosks, and drive-thru services, all operating across the United States and Canada. Its operations are divided into two main areas: Retail Pharmacy Services and Pharmacy Technology. A flagship product, the MedCenter system, facilitates on-site prescription dispensing in various environments such as medical clinics, retail stores, and employer sites, or any location desiring convenient, integrated pharmacy access. Crucially, it incorporates a secure audio-visual link to a licensed pharmacist, enabling patients to receive their medications directly while benefiting from real-time professional guidance and supervision. MedAvail also manages its own retail pharmacy platform, known as SpotRx. As of the close of 2021, the company had installed 81 MedCenter kiosks. MedAvail Holdings, Inc. maintains its headquarters in Mississauga, Canada.
Share Price
$1.41
Last synced: 2024-03-12
Market Cap
$914.81K
Change (1 day)
-16.57%
Change (1 year)
0.00%
Country
CA
Trade MedAvail Holdings, Inc. (MDVL)

Category

Healthcare
P/E ratio for MedAvail Holdings, Inc. (MDVL)
P/E ratio as of 2026 TTM: 0
According to MedAvail Holdings, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for MedAvail Holdings, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 23.71 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.17 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.